144 related articles for article (PubMed ID: 37846767)
1. Participation of lncRNAs in the development of diabetic complications: Systematic review and meta-analysis. I. Rat.
Cabrera-Najera LE; Chirino-Galindo G; Palomar-Morales M
Diabet Med; 2024 Feb; 41(2):e15244. PubMed ID: 37846767
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNAs: The hidden players in diabetes mellitus-related complications.
Hussein RM
Diabetes Metab Syndr; 2023 Oct; 17(10):102872. PubMed ID: 37797393
[TBL] [Abstract][Full Text] [Related]
3. Long Noncoding RNAs in Diabetes and Diabetic Complications.
Leung A; Natarajan R
Antioxid Redox Signal; 2018 Oct; 29(11):1064-1073. PubMed ID: 28934861
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNAs as potential diagnostic biomarkers for diabetes mellitus and complications: A systematic review and meta-analysis.
Su X; Huang H; Lai J; Lin S; Huang Y
J Diabetes; 2023 Dec; 16(2):. PubMed ID: 38140829
[TBL] [Abstract][Full Text] [Related]
6. H19: A Vital Long Noncoding RNA in the Treatment of Diabetes and Diabetic Complications.
Zhu L; Li Y; Xia F; Xue M; Wang Y; Jia D; Gao Y; Li L; Shi Y; Chen S; Xu G; Yuan C
Curr Pharm Des; 2022; 28(12):1011-1018. PubMed ID: 34895118
[TBL] [Abstract][Full Text] [Related]
7. The Impact of lncRNA on Diabetic Kidney Disease: Systematic Review and In Silico Analyses.
Zhao Y; Yan G; Mi J; Wang G; Yu M; Jin D; Tong X; Wang X
Comput Intell Neurosci; 2022; 2022():8400106. PubMed ID: 35528328
[TBL] [Abstract][Full Text] [Related]
8. The MALAT1-H19/miR-19b-3p axis can be a fingerprint for diabetic neuropathy.
Rajabinejad M; Asadi G; Ranjbar S; Varmaziar FR; Karimi M; Salari F; Karaji AG; Rezaiemanesh A; Hezarkhani LA
Immunol Lett; 2022 May; 245():69-78. PubMed ID: 35398394
[TBL] [Abstract][Full Text] [Related]
9. Current status and strategies of long noncoding RNA research for diabetic cardiomyopathy.
Pant T; Dhanasekaran A; Fang J; Bai X; Bosnjak ZJ; Liang M; Ge ZD
BMC Cardiovasc Disord; 2018 Oct; 18(1):197. PubMed ID: 30342478
[TBL] [Abstract][Full Text] [Related]
10. Expressions of Serum lncRNAs in Diabetic Retinopathy - A Potential Diagnostic Tool.
Biswas S; Coyle A; Chen S; Gostimir M; Gonder J; Chakrabarti S
Front Endocrinol (Lausanne); 2022; 13():851967. PubMed ID: 35464068
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of long noncoding RNAs in early diabetic retinopathy.
Yan B; Tao ZF; Li XM; Zhang H; Yao J; Jiang Q
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):941-51. PubMed ID: 24436191
[TBL] [Abstract][Full Text] [Related]
12. The Impact of lncRNAs in Diabetes Mellitus: A Systematic Review and
Dieter C; Lemos NE; Corrêa NRF; Assmann TS; Crispim D
Front Endocrinol (Lausanne); 2021; 12():602597. PubMed ID: 33815273
[TBL] [Abstract][Full Text] [Related]
13. Dysregulated expression of long noncoding RNAs serves as diagnostic biomarkers of type 2 diabetes mellitus.
Zhang W; Zheng J; Hu X; Chen L
Endocrine; 2019 Sep; 65(3):494-503. PubMed ID: 31346922
[TBL] [Abstract][Full Text] [Related]
14. Association of long non-coding RNA and leukemia: A systematic review.
Dieter C; Lourenco ED; Lemos NE
Gene; 2020 Apr; 735():144405. PubMed ID: 32014562
[TBL] [Abstract][Full Text] [Related]
15. Circulating long non-coding RNAs NKILA, NEAT1, MALAT1, and MIAT expression and their association in type 2 diabetes mellitus.
Alfaifi M; Ali Beg MM; Alshahrani MY; Ahmad I; Alkhathami AG; Joshi PC; Alshehri OM; Alamri AM; Verma AK
BMJ Open Diabetes Res Care; 2021 Jan; 9(1):. PubMed ID: 33436407
[TBL] [Abstract][Full Text] [Related]
16. Co-expression changes of lncRNAs and mRNAs in the cervical sympathetic ganglia in diabetic cardiac autonomic neuropathic rats.
Li G; Sheng X; Xu Y; Jiang H; Zheng C; Guo J; Sun S; Yi Z; Qin S; Liu S; Gao Y; Zhang C; Xu H; Wu B; Zou L; Liang S; Zhu G
J Neurosci Res; 2017 Aug; 95(8):1690-1699. PubMed ID: 27991686
[TBL] [Abstract][Full Text] [Related]
17. Variation in the expression level of MALAT1, MIAT and XIST lncRNAs in coronary artery disease patients with and without type 2 diabetes mellitus.
Sohrabifar N; Ghaderian SMH; Alipour Parsa S; Ghaedi H; Jafari H
Arch Physiol Biochem; 2022 Oct; 128(5):1308-1315. PubMed ID: 32447981
[No Abstract] [Full Text] [Related]
18. Evaluation of the expression levels of lncRNAs H19 and MEG3 in patients with type 2 diabetes mellitus.
Alrefai AA; Khader HF; Elbasuony HA; Elzorkany KM; Saleh AA
Mol Biol Rep; 2023 Jul; 50(7):6075-6085. PubMed ID: 37294471
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatics Analysis of the Mechanisms of Diabetic Nephropathy
Guo M; Dai Y; Jiang L; Gao J
Front Endocrinol (Lausanne); 2022; 13():934022. PubMed ID: 35909518
[TBL] [Abstract][Full Text] [Related]
20. Identification of the candidate lncRNA biomarkers for acute kidney injury: a systematic review and meta-analysis.
Ma T; Jia H; Ji P; He Y; Chen L
Expert Rev Mol Diagn; 2021 Jan; 21(1):77-89. PubMed ID: 33612038
[No Abstract] [Full Text] [Related]
[Next] [New Search]
